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Abstract 
Isolated noncompaction of the left ventricle (LV) is a rare disorder, classified as a primary genetic cardiomyopathy by the 
American Heart Association. The European Society of Cardiology Working Group on Myocardial and Pericardial Diseases classified 
LV noncompaction as an unclassified cardiomyopathy. LV noncompaction cardiomyopathy characterized by the following features: 
1) an altered myocardial wall with prominent trabeculae and deep intertrabecular recesses resulting in thickened myocardium with 
two layers, consisting of compacted and noncompacted myocardium and 2) continuity between the left ventricular cavity and the 
deep intertrabecular recesses, which are filled with blood from the ventricular cavity, without evidence of communication with the 
epicardial coronary artery system.  Features  of  LV  noncompaction can overlap with dilated cardiomyopathy, hypertrophic 
cardiomyopathy (especially the apical variant), and restrictive cardiomyopathy. The phenotypic expression can vary considerably 
within the same family. The LV noncompaction can rarely occur as a transient phenomenon during myocarditis. 
We present the case of a 23-year-old patient, admitted to our Department for cardiac evaluation because of ECG changes 
and cardiac enlargement revealed at thoracic radiography. She had a history of chronic toxoplasmosis. An echocardiography was 
performed revealing left ventricular enlargement with severe systolic and diastolic dysfunction, diffuse hypokinesia and signs of 
isolated left ventricular non-compaction. Under these circumstances, we have considered the presence of isolated left ventricular 
non-compaction. A cardiac Magnetic Resonance Imaging was performed and it sustained the diagnosis. The alternative cause of 
isolated left ventricular noncompaction (prominent trabeculation due to myocardial toxoplasmosis) was considered improbable. 
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Introduction 
The left ventricular (LV) isolated non-compaction 
is characterized by embryonic myocardium morphology 
due to an arrest in the compaction process during the first 
trimester, and it is a very rare cardiomyopathy. Clinical 
manifestations are non-specific, ranging from 
asymptomatic patients to acute congestive heart failure. 
The diagnosis is based on cardiac imaging using 
echocardiography and magnetic resonance imaging. 
Case report 
A healthy 23-year-old woman presented to 
hospital for cardiac workup after she had been referred to 
a cardiologist by a general practitioner, after detecting 
changes on electrocardiogram (ECG), consisting of 
negative T waves and cardiac enlargement on thoracic 
radiography. She was asymptomatic at presentation and 
without any familial cardiac history. She had a history of 
chronic toxoplasmosis (with fever and lymphadenopathy, 
12 months prior to this hospitalization) for which she was 
taking antibiotic treatment. The clinical examination 
showed pallor of skin and mucous membrane, maculo-
papular non-itching rash on the forearms and thighs. 
There were also mobile axillary enlarged (2 cm) lymph 
nodes not tender or painful with moderate hard 
consistency, hepatosplenomegaly,  blood pressure (BP) 
of 110/60 mmHg, heart rate (HR) of 70 b/min, regularly 
and apexian systolic murmur grade III/VI radiating to the 
axilla. Laboratory tests showed a discrete inflammatory 
syndrome (elevated erythrocyte sedimentation rate and 
C-reactive protein level), IgG antibodies to Toxoplasma in 
serum (1497,3 UI/mL).                                               Journal of Medicine and Life Vol. 5, Issue 1, January‐March 2012 
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Initial ECG (see Figure 1) showed poor r wave 
progression in V1-V3 leads and negative T waves in DI, 
DII, aVF, and V4-V6 leads and thoracic radiography (see 
Figure 2) showed an increased cardio-thoracic index. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
An echocardiogram (see Figure 3 A, B and C) 
was performed revealing left ventricular enlargement with 
severe systolic and diastolic dysfunction (LV ejection 
fraction 25%, filling pattern type III- restrictive pattern), 
diffuse hypokinesia and trabeculation suggesting isolated 
left ventricular non-compaction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A cardiac Magnetic Resonance Imaging (MRI) 
(see Figure 4 A and B) was performed and it confirmed 
dilated cardiomyopathy with excessively prominent 
trabeculations in left lateral wall and ventricular apex, 
severe alteration of left ventricular function with diffuse 
hypokinesia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1. ECG at presentation 
Fig 2. Chest radiography revealed heart enlargement 
Fig. 3A Echocardiography:  LV trabeculation 
Fig. 3B Echocardiography: LV  magnified view of 
trabeculae 
Fig. 3C LV filling pattern at echocardiography 
Fig. 4A Visualization of trabeculae at MRI (frontal view) 
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Discussion 
One of the most important questions in this case 
is the etiology of dilated cardiomyopathy: a non-
compacted or a secondary dilated cardiomyopathy. 
The left ventricular isolated non-compaction is a genetic 
cardiomyopathy and can occur isolated or in association 
with congenital heart defects, genetic syndromes and 
neuromuscular disorders. It is characterized by prominent 
trabeculations and deep recesses within the ventricular 
myocardium resulting in apparently hypertrophied 
myocardium. The myocardium is actually thickened and 
has two layers consisting of compacted and non-
compacted myocardium [1,2,3]. Normal myocardium can 
present trabeculae but always less than three, while in 
non-compaction, the trabeculae are increased in number 
and very prominent, the compact layer is thinner and 
between the trabeculae there are deep recesses in 
communications with the ventricular cavity, but not with 
the epicardial coronary system [3,4,5,6]. 
Most patients have systolic left ventricular 
dysfunction and they present with congestive heart failure. 
The diagnosis is given by the echocardiography. Current 
echocardiographic criteria include: a) presence of multiple 
trabeculae – especially in the apex and the left ventricular 
free wall; b) multiple deep recesses, between trabeculae, 
communicating with ventricular cavity (demonstrated by 
color Doppler imaging); c) a two-layer structure of the 
myocardium with non-compact increased layer (ratio 
between non-compact and compact layer suggested as 
>2.0) [5,6]. 
It is also known that left ventricular dilation, 
hypertrophy and systolic left ventricular dysfunction can 
present trabeculae and increased left ventricular bands. 
This is an apparent non-compaction and it can be difficult 
to differentiate by imagistic examination, even by using 
the proposed criteria [3]. A cause for dilated 
cardiomyopathy is known to be infectious myocarditis. 
The toxoplasma infection has a worldwide distribution and 
the primary infection is, in most cases, asymptomatic. The 
involvement of the myocardium is rare in immune-
competent hosts and a development of secondary dilated 
cardiomyopathy has not yet been described. Several 
cases of toxoplasma myocarditis were published in the 
past. In 1954, Paulley et al [7], concluded that myocardial 
toxoplasmosis should be considered in all obscure cases 
of myocarditis and unexplained cardiac hypertrophy. In 
1967, Arturo Arribada and Edgardo Escobar [8] concluded 
in a small study that cardiac failure might be due to a late 
complication of the toxoplasmic infection of heart and it is 
important that the proper diagnosis is made as early as 
possible. Despite these early reports we have not found 
any recent published cases of toxoplasma myocarditis in 
immune-competent host. 
Despite her medical history of chronic 
toxoplasmosis, the diagnosis we consider for our patient 
was non-compaction cardiomyopathy. We based our 
diagnosis on: absence of clinical manifestation regarding 
any episode of acute myocarditis; current clinical state - 
asymptomatic patient suggesting long term development 
of cardiac enlargement; cardiac imaging –
echocardiographic and MRI elements for non-compaction 
cardiomyopathy;  absence of suggestive literature data 
regarding dilated cardiomyopathy secondary to 
toxoplasma infection in immune-competent host; absence 
of regression, under treatment, suggesting genetic 
disorder instead of apparent non-compaction. 
An endomyocardial biopsy would have been 
useful, but presently, we have encountered technical 
difficulties along with the patient’s refusal and also genetic 
testing, both not being available yet. 
As in previous reported cases [9], there is no 
specific treatment in noncompaction cardiomyopathy. We 
have been closely monitoring her condition with clinical 
examination, ECG and echocardiography and, so far, 
there have been no changes; currently she remains 
asymptomatic and she is treated with a beta blocker, an 
angiotensin-converting enzyme inhibitor, an oral 
anticoagulant and an implantable cardioverter-defibrillator 
were proposed for primary prevention of sudden cardiac 
death. 
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